Cross-Cutting Engineering

Shelf-Life Studies

Real-time shelf-life studies track physical performance across storage conditions, scheduled pulls, lots, and product configurations.

We plan pull schedules, control storage conditions, retest defined attributes, and document drift for expiry, re-test, and product-change decisions.

ISO 17025ICH Q1A (R2)FDA shelf-life guidanceASTM F1980Reviewed 2026-05-16
Request a quoteSubmit a sample

Purpose & when to use

Shelf-life studies use controlled storage, scheduled pull points, and repeated analytical or performance measurements to show how products, devices, formulations, packages, and materials change over time. Depending on the product and decision, programs can align with ICH Q1A (R2), FDA shelf-life guidance, and ISO 17025 record requirements. Storage conditions, sample identity, method QC, and trend interpretation remain documented and traceable throughout the study:

  1. ICH Q1A (R2) real-time programs for inhalation products using chamber storage, scheduled pulls, and PSD or emitted-dose trending.
  2. FDA shelf-life guidance support for nasal sprays or consumer aerosols using leakage, corrosion, valve behavior, and appearance checks.
  3. ASTM F1980 accelerated-aging bridges for medical devices or packages when real-time shelf-life evidence is still maturing.
  4. USP <1118> distribution-risk programs for packaged products using excursion logs, pull records, and post-storage performance retesting.
  5. ISO 17025 change-control comparisons for valves, actuators, packages, or formulations using matched lots and shared pull schedules.

Use shelf-life studies when a decision depends on how a product changes during storage, not only on a single release result. Before samples enter storage, the study plan defines the conditions, pull timing, measured attributes, acceptance criteria, and approach to trend analysis.

Built for products, packages, and device programs

Shelf-life trending spans pharmaceutical, device, packaging, and consumer-product programs where ICH, FDA, ASTM, USP, or product-specific expectations shape storage evidence.

  • Inhalation productsMDI, DPI, nebulizer programs
  • Nasal spraysPump and unit-dose formats
  • Consumer aerosolsSprays, valves, packages
  • Medical devicesMaterials and performance attributes
  • PackagingConfigurations and storage protection

Instrumentation & measurement ranges

Study elements are selected based on the product, storage claim, and decision. The plan also defines condition logs and the readouts paired across pull points.

0 – 24 motrend

Controlled storage with scheduled pulls

Defined temperature/RH conditions, sample orientation, pull calendars, retain allocation, and chamber records tied to each tested sample group.

1 – 12 attrperformance

Performance trending readouts

PSD, emitted dose, spray/plume geometry, mass spray rate, valve behavior, leakage, or device output repeated at scheduled pulls.

1 – 5 checksinspection

Appearance and package checks

Visual inspection, corrosion checks, leakage indicators, package integrity notes, and photo logs captured when the product or container may drift.

1 – 20 analytesassay

Chemistry and by-product options

Assay, impurity, VOC, or by-product panels added when formulation drift, packaging interaction, or storage degradation is part of the decision.

Test method options

MethodStrengthsTradeoffAligned with
Core real-time trending program
  • Most representative storage evidence for ICH Q1A (R2) and FDA shelf-life decisions.
  • Pull calendars, retains, and repeated readouts create a traceable long-term record.
Decision timing is slower, so logistics and sample allocation must be controlled.
ICH Q1A (R2)FDA shelf-life guidance
Multi-condition storage sweep
  • Brackets storage variability under ICH Q1A (R2) while preserving ISO 17025 traceability.
  • Useful for lot, package, orientation, or consumer-storage comparisons.
More conditions increase sample count, chamber capacity needs, and pull testing.
ICH Q1A (R2)ISO 17025
Accelerated aging bridge
  • ASTM F1980 can support interim aging rationale while real-time evidence matures.
  • Helps screen package, material, device, or formulation changes before long pulls finish.
Acceleration assumptions must be bounded and confirmed against real-time results.
ASTM F1980FDA shelf-life guidance
Excursion and distribution add-on
  • USP <1118> framing links distribution excursions to later shelf-life performance.
  • Post-stress pulls compare stressed samples with unstressed retains.
Requires a defined stress profile and acceptance criteria before storage starts.
USP <1118>ISO 17025

Setup configurations

A shelf-life study begins with a written plan that defines the storage configuration before samples enter the chamber or retain area. For every scheduled pull, the plan links the sample history to the applicable method controls, acceptance criteria, and reporting purpose. This keeps trend decisions tied to documented conditions instead of context reconstructed later.

Environmental controls

Temperature/RH targets, chamber assignment, condition logging, calibration checks, and excursion review criteria.

Sample numbers

Pull schedule, retain allocation, replicate count, destructive-test needs, and replacement rules for missed or invalid pulls.

Sample matrix

Lot, formulation, device revision, package configuration, orientation, and storage state documented before conditioning.

Exposure profile

Real-time condition, secondary condition, accelerated bridge, or distribution stress selected for the decision under study.

Chain of custody

Receipt, storage transfer, pull execution, readout handoff, and final disposition recorded for each sample group.

Quality anchors for shelf-life evidence

A shelf-life study needs its quality framework defined before storage begins. The plan establishes how conditions, sample pulls, method controls, and deviations will be documented, as well as how evidence for expiry or change-control decisions will be reviewed.

  • ISO 17025AccreditedTesting-laboratory competence, traceable records, calibration control, and uncertainty contributors.
  • ICH Q1A (R2)AlignedLong-term stability condition selection, pull timing, and trend interpretation.
  • FDA shelf-life guidanceAlignedSubmission-facing shelf-life evidence, storage claims, and documented rationale.
  • ASTM F1980AlignedAccelerated aging rationale used when real-time evidence is still maturing.

Key data outputs & reporting

Shelf-life programs provide the storage-condition history, pull-point results, and trend interpretation used for expiry, re-test interval, storage, or product-change decisions. Reports document the study plan, assumptions, acceptance criteria, chamber events, paired methods, and contributors to uncertainty. Results are organized by time, condition, lot, package, device revision, endpoint, and acceptance outcome. Change-control and shelf-life extension programs also include supporting appendices alongside the base report.

Primary outputs

  • Trend tables for performance attributes such as PSD, emitted dose, plume geometry, leakage, corrosion, appearance, assay, or VOCs.
  • Condition logs, chamber excursions, pull execution records, and sample identity checks tied to each result set.
  • Drift-rate discussion and out-of-trend flags with assumptions, limits, and acceptance criteria stated.

Deliverables

#FormatContents
01PDF reportStudy plan, conditions, controls, results, trend interpretation, and assumptions.
02CSV / XLSX datasetsPull-point results, chamber logs, trend tables, and calculated deltas.
03FiguresTrend plots, overlays, inspection photo logs, and condition comparisons.
Extended deliverables · multi-arm comparability · stability · predicate studies
  • Shelf-life appendix — Drift rates, confidence intervals, and expiry or re-test interval rationale.
  • Change-control pack — Side-by-side trends for package, valve, actuator, material, formulation, or lot revisions.
  • Excursion summary — Stress profile, condition records, and comparison to unstressed retains.

QA / QC & data integrity

Shelf-life data are useful only when storage history, pull execution, and paired methods remain traceable. QA / QC controls cover chamber readiness, sample identity, pull checklists, method QC, and exception handling from sample receipt through final reporting. The study file preserves the trend data together with the storage and test conditions that produced them.

Chamber calibration, verification, and condition logs reviewed against the study plan.

Pull-point checklists, sample identity verification, and chain-of-custody records for every sample group.

Method QC for each readout, including controls, calibration checks, blanks, repeats, or recovery checks as applicable.

Defined acceptance criteria for chamber excursions, outliers, missed pulls, and out-of-trend flags.

Inspection photos or diagrams when orientation, package state, corrosion, or device setup affects interpretation.

RESEARCH / THIS WORK IN PRACTICE

Real studies. Measured evidence.

Explore published studies connected to shelf-life studies. Each explains the study question, approach and findings.

View related studies (1)
Packaging & Stability

Cosmetic wand-package testing: temperature and altitude

The study separated temperature-related formulation and applicator behavior from reduced-pressure leakage risk in three anonymized package variants.

Selected finding
At 40 °C, maximum losses were 93 mg, 52 mg, and 51 mg; the 93 mg result came from one anomalous unit, while the maximum among the remaining Variant A units was 46 mg.
Related context

The published article connects storage observations with condition-driven shelf-life questions.

PackagingEnvironmental simulationProduct evaluation

Study-specific findings do not guarantee performance for another product.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
17025Accredited testing
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

Shelf-life questions often come from quality, regulatory, product, packaging, and device teams deciding how much time-based evidence is needed for an expiry, re-test, storage, or change-control decision. The answers below cover real-time and accelerated evidence, attributes measured at each pull point, storage conditions, sample counts, and typical deliverables. Products or regulatory frameworks with different requirements may call for a different study structure.

Q.How is real-time shelf-life different from accelerated aging?
A.Real-time shelf-life measures drift under defined storage over calendar time. Accelerated aging applies stress to estimate risk earlier. Many programs use accelerated data only as a bridge until real-time pulls mature.
Q.What should be measured at each pull?
A.At each pull, we measure attributes tied to the shelf-life decision, such as PSD, emitted dose, leakage, corrosion, appearance, assay, impurities, VOCs, or package integrity. The pull matrix is defined before storage begins.
Q.Can you include multiple storage conditions?
A.Yes. Programs can include a primary long-term condition, secondary temperature/RH conditions, distribution excursions, or accelerated legs when the product risk and decision justify the added samples.
Q.What drives sample count?
A.Sample count depends on conditions, pull points, endpoints, replicates, destructive tests, lots, and retains. We build an allocation table so every pull has enough test and backup material.
Q.What do shelf-life deliverables include?
A.A typical data package includes a PDF report, CSV or XLSX trend tables, chamber logs, pull records, figures, inspection photos, and discussion of drift, uncertainty, and assumptions.

Standards & guidance

Shelf-life studies are scoped around the product, the decision, and the applicable regulatory framework. ARE Labs uses ISO 17025 as the quality-system anchor for traceable testing and aligns study design with ICH, FDA, ASTM, and USP guidance where applicable. The standards below are commonly used to plan pull points, establish the aging rationale, connect distribution conditions to the study, and structure reporting.

QA & Regulatory - Accredited

ISO 17025

Testing-laboratory competence, traceable records, calibration control, and uncertainty contributorsView standard ->Stability & Shelf Life - Aligned

ICH Q1A (R2)

Stability testing of new drug substances and products, including condition selection and pull timingView standard ->QA & Regulatory - Aligned

FDA shelf-life guidance

FDA expectations for shelf-life evidence, expiry rationale, storage claims, and documented trendingView standard ->Stability & Shelf Life - Aligned

ASTM F1980

Accelerated aging of sterile barrier systems and medical devices when real-time evidence is still maturingView standard ->Pharmacopeial - Aligned

USP <1118>

Monitoring and interpreting distribution, storage, and transport conditions for pharmaceutical articlesView standard ->

Related services & devices

Service

Stability and Accelerated Aging

Pairs with shelf-life trending when accelerated evidence or stress legs need to bridge until real-time pulls mature.Read more ->Devices

Drug Delivery

Inhalation, nasal, and oral delivery devices often need storage evidence across formulation, actuator, or package changes.Read more ->Service

VOC and By-Product Emissions

Adds chemistry drift evidence when storage may change emissions, residuals, propellants, or degradation products.Read more ->Devices

Spray & Aerosol

Consumer sprays and aerosol packages use shelf-life studies to evaluate valve, package, leakage, and appearance drift.Read more ->